Omzet 2024 * | 81,33 mln. 74,84 mln. | Omzet 2025 * | 78,22 mln. 71,98 mln. | Marktkapitalisatie | 17,82 mln. 16,4 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -13 mln. -11,96 mln. | Nettowinst (verlies) 2025 * | 4 mln. 3,68 mln. | EV/omzet 2024 * | 0,22 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,23 x |
K/w-verhouding 2024 * |
-1,29
x | K/w-verhouding 2025 * |
4,16
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,43% |
Recentste transcriptie over Aytu Bioscience Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16-04-15 |
Jarrett Disbrow
FOU | Founder | 49 | 16-04-15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 17-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 01-07-22 |
Jarrett Disbrow
FOU | Founder | 49 | 16-04-15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16-04-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,55% | 727 mld. | |
-7,94% | 354 mld. | |
+15,46% | 328 mld. | |
-0,59% | 277 mld. | |
+13,47% | 243 mld. | |
+7,35% | 205 mld. | |
-6,42% | 203 mld. | |
+3,88% | 164 mld. | |
-2,24% | 164 mld. |